Noelynn Oliver Selected Research

Connective Tissue Growth Factor

7/2011	Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII.
6/2011	Connective tissue growth factor is increased in pseudoexfoliation glaucoma.
2/2011	Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.
6/2010	Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion.
11/2008	CTGF inhibits BMP-7 signaling in diabetic nephropathy.
9/2008	Connective tissue growth factor as a mediator of intraocular fibrosis.
7/2008	The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy.
6/2008	Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.
10/2006	Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.
6/2006	Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noelynn Oliver Research Topics

Disease

8	Fibrosis (Cirrhosis) 01/2017 - 07/2003
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2012 - 05/2004
4	Epiretinal Membrane (Epiretinal Membranes) 09/2008 - 03/2004
3	Albuminuria 01/2017 - 05/2004
3	Proliferative Vitreoretinopathy 07/2011 - 10/2006
3	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2008 - 03/2004
2	Proteinuria 01/2017 - 05/2004
2	Ureteral Obstruction 01/2017 - 02/2011
2	Retinal Perforations 07/2008 - 10/2006
2	Cicatrix (Scar) 07/2008 - 10/2006
1	Cardiomegaly (Heart Hypertrophy) 01/2017
1	Glaucoma 06/2011
1	Cataract (Cataracts) 06/2011
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2011
1	Peritoneal Fibrosis 03/2010
1	Renal Insufficiency (Renal Failure) 03/2010
1	Blindness (Hysterical Blindness) 07/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2008
1	Diabetes Complications 05/2004
1	Rhabdomyosarcoma 03/2004
1	Peritonitis 07/2003

Drug/Important Bio-Agent (IBA)

13	Connective Tissue Growth FactorIBA 07/2011 - 03/2004
3	Messenger RNA (mRNA)IBA 01/2017 - 11/2008
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2004
3	TRPC6 Cation ChannelIBA 01/2017 - 01/2017
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2012 - 02/2011
2	CytokinesIBA 02/2011 - 07/2003
2	Biomarkers (Surrogate Marker)IBA 03/2010 - 05/2004
2	Dialysis SolutionsIBA 03/2010 - 07/2003
1	CalciumIBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Retinal Pigments (Pigments, Visual)IBA 07/2011
1	Fibronectins (Fibronectin)IBA 07/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2011
1	pamrevlumabIBA 02/2011
1	CollagenIBA 02/2011
1	Hydroxyproline (4 Hydroxyproline)IBA 02/2011
1	Proline (L-Proline)FDA Link 02/2011
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2010
1	Bone Morphogenetic Protein 7IBA 11/2008
1	Matrix Metalloproteinases (MMPs)IBA 11/2008
1	Retinaldehyde (Retinal)IBA 09/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2008
1	ImmunosorbentsIBA 10/2006
1	EnzymesIBA 10/2006
1	CreatinineIBA 05/2004
1	Cysteine (L-Cysteine)FDA Link 03/2004
1	Myosins (Myosin)IBA 03/2004
1	Antisense OligonucleotidesIBA 03/2004
1	Small Interfering RNA (siRNA)IBA 03/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2003

Therapy/Procedure

2	Peritoneal Dialysis 03/2010 - 07/2003
1	Trabeculectomy (Trabeculoplasty) 06/2011
1	Intraperitoneal Injections 02/2011
1	Therapeutics 03/2010
1	Injections 09/2008
1	Lasers (Laser) 07/2008